Synthetic Biology Market to Grow at 6.5% CAGR Through 2031, Fueled by Precision Medicine & Sustainable Biomanufacturing | Amyris Inc, Algenol Biofuels Inc, CBC Comprehensive Biomarker Center, Biosearch Technologies Inc, Gene Script Corporation, GeneWorks

Synthetic Biology Market is estimated to reach at a CAGR of 6.5% during the forecast period 2024-2031.

The Synthetic Biology Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/synthetic-biology-market?sg

Synthetic Biology Market Drivers:
Rising Demand for Precision Medicine
Synthetic biology enables the creation of custom genetic circuits and engineered organisms, supporting innovations in gene therapy, diagnostics, and personalized medicine. The demand for targeted therapeutics is a significant driver, especially in oncology and rare diseases.

Growing Applications in Agriculture
Genetically engineered crops and microbes are being developed to improve crop yield, resist pests, and reduce dependency on chemical fertilizers. Synthetic biology plays a central role in the development of climate-resilient agriculture and biofertilizers.

Sustainable Manufacturing and Bio-Based Products
With growing concerns about carbon emissions and plastic pollution, synthetic biology is enabling the production of sustainable alternatives such as biofuels, bioplastics, and biodegradable materials. This aligns with global efforts toward decarbonization and circular economy goals.

Technological Advancements and Falling DNA Synthesis Costs
Advancements in genome editing tools (like CRISPR), high-throughput DNA sequencing, and automated gene synthesis platforms are making synthetic biology more accessible and cost-effective. This has led to a surge in innovation across academia and industry.

Expanding Industrial and Environmental Applications
Beyond healthcare, synthetic biology is being applied in the development of enzymes, bio-based chemicals, and environmental solutions such as wastewater treatment and pollution detection. These diverse applications broaden the market potential significantly.

Synthetic Biology Market - Geographical Share

North America holds a dominant share in the global synthetic biology market, largely driven by the United States. The region benefits from strong government and private sector investments, well-established biotech infrastructure, and a high concentration of academic and research institutions. The presence of major synthetic biology startups and active collaboration between industry and academia further fuels growth.

Europe represents the second-largest market, with countries such as Germany, the UK, and France at the forefront. The region is focused on sustainable industrial practices and green biotechnology, leading to increased adoption of synthetic biology in agriculture, energy, and pharmaceuticals. Regulatory support for bio-based products and initiatives such as Horizon Europe boost regional innovation.

The Asia-Pacific region is witnessing the fastest growth due to expanding biotech industries in China, India, Japan, and South Korea. Increasing government initiatives, supportive regulatory frameworks, and rising demand for synthetic biology applications in healthcare and agriculture are key growth enablers. Local biotech clusters and increased academic output are also enhancing regional competitiveness.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/synthetic-biology-market?sg

Strategic Players Driving the Synthetic Biology Market: Amyris Inc., Algenol Biofuels Inc., Bayer AG, CBC Comprehensive Biomarker Center GmbH, Bristol-Myers Squibb, Biosearch Technologies Inc., Gene Script Corporation, GeneWorks Pty Ltd., DuPont Inc and Thermo Fisher Scientific.

Research Methodology:

The global Synthetic Biology Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Synthetic Biology Market:

By-Products (Core Product (Synthetic Genes, Synthetic DNA, Synthetic Cells, Chassis Organisms, XNA), Enabling Product (Oligonucleotide Synthesis, DNA Synthesis))
By Technologies (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement & Modeling, Microfluidics)
By Application (Healthcare, Food & Agriculture, Chemicals, Others)
By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Mergers & Acquisitions:
Eli Lilly → Verve Therapeutics: In June 2025, Eli Lilly agreed to acquire CRISPR-based gene‐editing biotech Verve Therapeutics for up to $1.3 billion (≈ $1 b upfront, up to $300 m in milestones). Verve's lead therapy targets the PCSK9 gene for cardiovascular disorders, entering Phase II trials-this marks one of the first public gene‐editing biotech M&A in a cooling market.

Inscripta → Synthego: In February 2025, Inscripta acquired Synthego to integrate CRISPR editing tools with automated biofoundry capabilities streamlining cell‐line engineering workflows.

Strategic Partnerships & Collaborations:
Ginkgo Bioworks & Bayer (May 2025): Announced a collaboration to co‐develop microbial strains for sustainable agricultural inputs, aiming to reduce reliance on chemical fertilizers.

Merck & Pearl Bio (2025): Entered a partnership worth up to $1 billion in milestones to create tunable cancer biologics using synthetic chemistry and cell engineering platforms.

Regional Analysis for Synthetic Biology Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Synthetic Biology Market Research Industry:

➠ Who leads the Synthetic Biology industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Synthetic Biology market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Synthetic Biology market growth?

➠ What are the dominant sales and distribution strategies in the Synthetic Biology industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.